BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6096961)

  • 1. Diagnosis of Hodgkin's disease hampered by an Epstein-Barr virus infection treated with acyclovir.
    Berild D; Bendtzen K; Badsberg E
    Scand J Haematol; 1984 Nov; 33(5):448-52. PubMed ID: 6096961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of Hodgkin's lymphoma after infectious mononucleosis.
    Hjalgrim H; Askling J; Rostgaard K; Hamilton-Dutoit S; Frisch M; Zhang JS; Madsen M; Rosdahl N; Konradsen HB; Storm HH; Melbye M
    N Engl J Med; 2003 Oct; 349(14):1324-32. PubMed ID: 14523140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity of Epstein-Barr virus in Hodgkin's disease preceded by infectious mononucleosis.
    Band PR; Levine PH; Patwardhan VC; Shnitka TK; Pabst HF
    Can Med Assoc J; 1973 Jan; 108(2):183-6. PubMed ID: 4346314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that amphotericin B mediates reactivation of latent Epstein-Barr virus in Hodgkin's lymphoma allowing cytotoxicity by acyclovir.
    Kast RE
    Yonsei Med J; 2006 Apr; 47(2):287-90. PubMed ID: 16642564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association of nephrotic syndrome and Hodgkin's disease. Role of the Epstein-Barr virus].
    Berthoux FC; Zech PY; Blanc-Brunat N; Colon S; Ducret F; Traeger J
    Nouv Presse Med; 1976 Jan; 5(5):255-8. PubMed ID: 177950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurologic complications of Epstein-Barr virus. Clinical contributions with a description of a complex case treated with acyclovir].
    Galluzzi F; Belisario C; Rosati C; Seminara S; Salti R
    Minerva Pediatr; 1988 Jun; 40(6):361-5. PubMed ID: 2846997
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymphadenopathy morphologically consistent with Hodgkin's disease associated with Epstein-Barr virus infection.
    Poppema S; van Imhoff G; Torensma R; Smit J
    Am J Clin Pathol; 1985 Sep; 84(3):385-90. PubMed ID: 2994459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Epstein-Barr virus:host balance in acute infectious mononucleosis patients receiving acyclovir anti-viral therapy.
    Yao QY; Ogan P; Rowe M; Wood M; Rickinson AB
    Int J Cancer; 1989 Jan; 43(1):61-6. PubMed ID: 2536008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coma as a presenting sign of Epstein-Barr encephalitis.
    Demey HE; Martin JJ; Leus RM; Moeremans CJ; Bossaert LL
    Arch Intern Med; 1988 Jun; 148(6):1459-61. PubMed ID: 2837158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus.
    Bacchi CE; Bacchi MM; Rabenhorst SH; Soares FA; Fonseca LE; Barbosa HS; Weiss LM; Gown AM
    Am J Clin Pathol; 1996 Feb; 105(2):230-7. PubMed ID: 8607450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus infection associated with interstitial nephritis and chronic fatigue.
    López-Navidad A; Domingo P; López-Talavera JC; Rabella N; Verger G
    Scand J Infect Dis; 1996; 28(2):185-7. PubMed ID: 8792488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-barr virus and hodgkin lymphoma.
    Ambinder RF
    Hematology Am Soc Hematol Educ Program; 2007; ():204-9. PubMed ID: 18024631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acyclovir efficiently inhibits oropharyngeal excretion of Epstein-Barr virus in patients with acute infectious mononucleosis.
    Ernberg I; Andersson J
    J Gen Virol; 1986 Oct; 67 ( Pt 10)():2267-72. PubMed ID: 3020162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Epstein-Barr virus infections.
    Andersson J; Ernberg I
    Am J Med; 1988 Aug; 85(2A):107-15. PubMed ID: 2841854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus infection and its role in the expanding spectrum of human diseases.
    Okano M
    Acta Paediatr; 1998 Jan; 87(1):11-8. PubMed ID: 9510440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus, fatal infectious mononucleosis, and Hodgkin's disease in siblings.
    Veltri RW; Shah SH; McClung JE; Klingberg WG; Sprinkle PM
    Cancer; 1983 Feb; 51(3):509-20. PubMed ID: 6295604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte responses to EBV-associated antigens in infectious mononucleosis, and Hodgkin's and non-Hodgkin's lymphoma patients, with the leukocyte adherence inhibition assay.
    Chan SH; Wallen WC; Levine PH; Periman P; Perlin E
    Int J Cancer; 1977 Mar; 19(3):356-63. PubMed ID: 191408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acyclovir treatment in primary Epstein-Barr virus infection. A double-blind placebo-controlled study.
    Andersson J; Sköldenberg B; Ernberg I; Britton S; Henle W; Andersson U
    Scand J Infect Dis Suppl; 1985; 47():107-15. PubMed ID: 3006226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hodgkin's lymphoma, Epstein-Barr virus reactivation and fatal haemophagocytic syndrome.
    Hasselblom S; Linde A; Ridell B
    J Intern Med; 2004 Feb; 255(2):289-95. PubMed ID: 14746567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.